-
Product Insights
Lupus Nephritis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Lupus Nephritis Clinical Trial Report Overview A total of 434 lupus nephritis clinical trials were conducted as of February 2024. The lupus nephritis clinical trial report provides a comprehensive understanding of the lupus nephritis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       North...
-
Product Insights
Lupus Nephritis – Drugs In Development, 2023
Global Markets Direct’s, ‘Lupus Nephritis - Drugs In Development, 2023’, provides an overview of the Lupus Nephritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lupus Nephritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Cutaneous Lupus Erythematosus – Drugs In Development, 2023
Global Markets Direct’s, ‘Cutaneous Lupus Erythematosus - Drugs In Development, 2023’, provides an overview of the Cutaneous Lupus Erythematosus pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cutaneous Lupus Erythematosus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) - Drugs In Development, 2023’, provides an overview of the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers...
-
Product Insights
Subacute Cutaneous Lupus Erythematosus (SCLE) – Drugs In Development, 2023
Global Markets Direct’s, ‘Subacute Cutaneous Lupus Erythematosus (SCLE) - Drugs In Development, 2023’, provides an overview of the Subacute Cutaneous Lupus Erythematosus (SCLE) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Subacute Cutaneous Lupus Erythematosus (SCLE), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Cutaneous Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cutaneous Lupus Erythematosus Clinical Trials Overview The Cutaneous Lupus Erythematosus clinical trial report consists of 138 trials. The report provides an overview of the Cutaneous Lupus Erythematosus clinical trials scenario. The report provides top-line data relating to the clinical trials on Cutaneous Lupus Erythematosus. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
-
Product Insights
Systemic Lupus Erythematosus Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Systemic Lupus Erythematosus Clinical Trials Market Report Overview The Systemic Lupus Erythematosus clinical trial market research report provides an overview of the Systemic Lupus Erythematosus Clinical trials scenario. This report provides top-line data relating to the clinical trials on Systemic Lupus Erythematosus and an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status,...
-
Sector Analysis
Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Analysis and Forecast to 2031
Systemic Lupus Erythematosus and Lupus Nephritis Market Report Overview The diagnosed incident cases of Systemic Lupus Erythematosus (SLE) were 36,601 in the seven major markets (7MM) in 2021 and are expected to achieve an AGR of less than 1%. Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a chronic relapsing and remitting course, having variable manifestations ranging from mild to life-threatening illness (Tsokos, 2011). In SLE, the immune system attacks its own tissues, causing widespread inflammation and tissue...